Related Experiment Video
Updated: May 10, 2026

Phagosome Migration and Velocity Measured in Live Primary Human Macrophages Infected with HIV-1
Published on: September 5, 2016
Macrophage Resistance to HIV-1 Infection Is Enhanced by the Neuropeptides VIP and PACAP
Jairo R Temerozo1, Rafael Joaquim, Eduardo G Regis
1Laboratory on Thymus Research, Oswaldo Cruz Institute/Fiocruz, Rio de Janeiro, Brazil.
Abstract:
It is well established that host factors can modulate HIV-1 replication in macrophages, critical cells in the pathogenesis of HIV-1 infection due to their ability to continuously produce virus. The neuropeptides VIP and PACAP induce well-characterized effects on macrophages through binding to the G protein-coupled receptors VPAC1, VPAC2 and PAC1, but their influence on HIV-1 production by these cells has not been established. Here, we describe that VIP and PACAP reduce macrophage production of HIV-1, acting in a synergistic or additive manner to decrease viral growth. Using receptor antagonists, we detected that the HIV-1 inhibition promoted by VIP is dependent on its ligation to VPAC1/2, whereas PACAP decreases HIV-1 growth via activation of the VPAC1/2 and PAC1 receptors. Specific agonists of VPAC2 or PAC1 decrease macrophage production of HIV-1, whereas sole activation of VPAC1 enhances viral growth. However, the combination of specific agonists mimicking the receptor preference of the natural neuropeptides reproduces the ability of VIP and PACAP to increase macrophage resistance to HIV-1 replication. VIP and PACAP up-regulated macrophage secretion of the β-chemokines CCL3 and CCL5 and the cytokine IL-10, whose neutralization reversed the neuropeptide-induced inhibition of HIV-1 replication. Our results suggest that VIP and PACAP and the receptors VPAC2 and PAC1 could be used as targets for developing alternative therapeutic strategies for HIV-1 infection.
Insights
Neuropeptides vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) reduce HIV-1 replication in macrophages. These findings suggest VIP, PACAP, and their receptors as potential therapeutic targets for HIV-1 infection.
Area of Science:
- Immunology
- Virology
- Neuroendocrinology
Background:
- Macrophages are key in HIV-1 pathogenesis, continuously producing the virus.
- Host factors significantly influence HIV-1 replication within macrophages.
- Neuropeptides vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) affect macrophage functions via G protein-coupled receptors (VPAC1, VPAC2, PAC1).
Purpose of the Study:
- To investigate the impact of VIP and PACAP on HIV-1 production by macrophages.
- To elucidate the specific receptors mediating the effects of VIP and PACAP on HIV-1 replication.
Main Methods:
- Treatment of macrophages with VIP and PACAP.
- Assessment of HIV-1 production levels.
- Utilized receptor antagonists and specific agonists for VPAC1, VPAC2, and PAC1.
- Measured secretion of β-chemokines (CCL3, CCL5) and cytokine IL-10.
- Neutralization assays for secreted factors.
Main Results:
- VIP and PACAP synergistically or additively decrease HIV-1 production in macrophages.
- VIP's inhibitory effect is mediated by VPAC1/2 receptors; PACAP acts via VPAC1/2 and PAC1.
- Activation of VPAC2 or PAC1 inhibits HIV-1 production, while VPAC1 activation enhances it.
- VIP and PACAP upregulate CCL3, CCL5, and IL-10 secretion, which mediate the antiviral effect.
Conclusions:
- VIP and PACAP exhibit potent antiviral activity against HIV-1 in macrophages.
- The findings highlight VPAC2 and PAC1 receptors as promising targets for novel HIV-1 therapies.
- Targeting these neuropeptide-receptor pathways could offer alternative therapeutic strategies for HIV-1 infection.
Related Concept Videos
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Immune Surveillance by NK Cells and Phagocytes
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Cell-mediated Immune Responses
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...

